Peter O’Gorman
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Bone health and treatments
- Cancer Treatment and Pharmacology
Papers in
- Hematology 50
- Multiple Myeloma Research and Treatments 41
- Blood groups and transfusion 4
- Oncology 21
- Peptidase Inhibition and Analysis 13
- Cancer Treatment and Pharmacology 4
- Co-authors
- Paul Dowling (22 shared papers)MARTIN M. CLYNES (11 shared papers)Despina Bazou (20 shared papers)Tadhg G. Gleeson (3 shared papers)Conor P. Shortt (2 shared papers)Stephen J Eustace (2 shared papers)Abdul Hameed (4 shared papers)Jennifer J. Brady (3 shared papers)
- Journals
- Blood (10 papers)British Journal of Haematology (5 papers)Cancers (5 papers)Clinica Chimica Acta (3 papers)Drug and Alcohol Dependence (3 papers)
- Partner nations
- IrelandUnited StatesUnited Kingdom
In The Last Decade
Peter O’Gorman
79 papers receiving 2.6k citations
Peter O’Gorman's Hit Papers
Peers
Comparison fields: 5 of 119
- Hematology 1.5k
- Oncology 781
- Genetics 163
- Molecular Biology 1.0k
- Immunology 238
Countries citing papers authored by Peter O’Gorman
This map shows the geographic impact of Peter O’Gorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter O’Gorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter O’Gorman more than expected).
Fields of papers citing papers by Peter O’Gorman
This network shows the impact of papers produced by Peter O’Gorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter O’Gorman. The network helps show where Peter O’Gorman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter O’Gorman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 324 | |
| 2 | Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 316 |
| 3 | 2015 | 206 | |
| 4 | 2009 | 145 | |
| 5 | 2014 | 143 | |
| 6 | 2008 | 129 | |
| 7 | 2019 | 98 | |
| 8 | 2017 | 84 | |
| 9 | 2011 | 71 | |
| 10 | 1999 | 70 | |
| 11 | 2021 | 61 | |
| 12 | 2013 | 60 | |
| 13 | 2019 | 60 | |
| 14 | 2009 | 58 | |
| 15 | 2021 | 54 | |
| 16 | 2013 | 48 | |
| 17 | 2021 | 45 | |
| 18 | Blood vitamin status (B1, B2, B6, folic acid and B12) in patients with alcoholic liver disease. | 1982 | 43 |
| 19 | 2016 | 43 | |
| 20 | 1962 | 40 |
About Peter O’Gorman
Peter O’Gorman is a scholar working on Hematology, Oncology, Molecular Biology, Pathology and Forensic Medicine and Epidemiology, having authored 83 papers that have together received 2.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (41 papers), Protein Degradation and Inhibitors (15 papers), Peptidase Inhibition and Analysis (13 papers), Liver Disease Diagnosis and Treatment (5 papers), COVID-19 Clinical Research Studies (4 papers), Advanced Proteomics Techniques and Applications (4 papers), Blood groups and transfusion (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Hematology (1.5k citations), Oncology (781 citations), Genetics (163 citations), Molecular Biology (1.0k citations) and Immunology (238 citations). Peter O’Gorman has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Paul Dowling, MARTIN M. CLYNES, Despina Bazou, Tadhg G. Gleeson, Conor P. Shortt, Stephen J Eustace, Abdul Hameed, Jennifer J. Brady, Kenneth Carl Anderson and Shanta Patel. Their work appears in journals such as Blood, British Journal of Haematology, Cancers, Clinica Chimica Acta and Drug and Alcohol Dependence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.